F073 Transformation of Dermatology through Digital Dermatopathology: Practice Opportunities and Challenges
DESCRIPTION
Innovations in whole slide scanning technology, artificial intelligence and access to big data are resulting in dramatic shifts in the practice of dermatopathology. However, few laboratories are utilizing digital dermatopathology at scale. Our session aims to highlight opportunities and challenges associated with the implementation of digital dermatopathology, algorithms to support dermatopathology diagnosis, ‘real-life’ scenarios encountered in a fully transformed digital dermatopathology practice, and perspectives reflecting the spectrum of expertise provided by our diverse expert speaker panel.
LEARNING OBJECTIVES
Describe best practices/standards for implementation of digital dermatopathology to support a clinical dermatology practice.
Examine current and potential future roles for digital dermatopathology and artificial intelligence in the transformation of dermatology practice and education.
Discuss the workforce and reimbursement implications of digital dermatopathology in practice.
SCHEDULE
3:35 PM
Promise of AI and Digital Pathology in Practice: Workforce and Reimbursement Implications
Anil Parwani MD
4:00 PM
Six Years of Experience in a Fully Implemented Digital Dermatopathology Lab
Curtis T. Thompson, MD
4:25 PM
Nuts and Bolts of Digital Dermatopathology
Nneka I. Comfere, MD, FAAD
4:40 PM
Remote Dermatopathology
Margot S. Peters, MD, FAAD
4:47 PM
Digital Dermatopathology Implementation in Practice
Olayemi Sokumbi, MD, FAAD
5:00 PM
Panel Discussion
DIRECTOR
Olayemi Sokumbi, MD, FAAD
CO-DIRECTOR
Nneka I. Comfere, MD, FAAD
SPEAKERS
Anil Parwani MD
Margot S. Peters, MD, FAAD
Curtis T. Thompson, MD
DISCLOSURES
Nneka I. Comfere, MD, FAAD
No financial relationships exist with ineligible companies.
Anil Parwani MD
No financial relationships exist with ineligible companies.
Margot S. Peters, MD, FAAD
No financial relationships exist with ineligible companies.
Olayemi Sokumbi, MD, FAAD
No financial relationships exist with ineligible companies.
Curtis T. Thompson, MD
CTA Pathology – Founder(Salary);